Novartis could have a U.S. deal that shields it from tariffs, CEO tells CNBC
Strong Bearish
-100.0
The continent's pharma sector could be one of its worst hit by Trump's latest tariffs on some European countries.
Pulse AI Analysis
Pulse analysis not available yet. Click "Get Pulse" above.
This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.
